A New European Consortium Dedicated to Finding and Treating Rare Diseases

A molecular biologist, Dr. Daria Julkowska, coordinates an international consortium in Paris that is largely funded through the 28-member European Union (EU). According to a report published in the Charcot-Marie-Tooth…

Continue Reading A New European Consortium Dedicated to Finding and Treating Rare Diseases
Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks
qimono / Pixabay

Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks

According to a story from Angioedema News, a recent study demonstrated the effectiveness of the medication Haegarda in reducing the number of swelling attacks experienced by hereditary angioedema patients. Preventative…

Continue Reading Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks

Many Americans Medical Data and Images Are Easily Accessible Online. What Does This Mean for Rare Disease Patients?

According to a story from ProPublica, the computer servers that store important patient medical data are surprisingly unprotected. This lack of protection appears to be a problem around the world,…

Continue Reading Many Americans Medical Data and Images Are Easily Accessible Online. What Does This Mean for Rare Disease Patients?
Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial
Free-Photos / Pixabay

Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial

According to a story from globenewswire.com, the gene and cell therapy company Abeona Therapeutics Inc. recently announced that has received a letter from the US Food and Drug Administration (FDA)…

Continue Reading Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial
A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses
mcmurryjulie / Pixabay

A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

According to a post from gaucherdisease.org, clinical trials are an essential component to the development and testing of new therapies for Gaucher disease and other rare diseases. For some rare…

Continue Reading A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

FDA Approval Was Granted For a Duchenne Muscular Dystrophy Drug Amid Internal Disagreements

  The accelerated approval granted by the FDA for the Duchenne muscular dystrophy drug eteplirsen, developed by Sarepta Therapeutics, was granted only after internal disagreements and protests had been resolved.…

Continue Reading FDA Approval Was Granted For a Duchenne Muscular Dystrophy Drug Amid Internal Disagreements

In Honor of Tay-Sachs Disease Awareness Month Organizations are Teaming Together to Spread Awareness of Genetic Testing

Tay-Sachs Disease September is Tay-Sachs Disease Awareness Month. Voted on by the Senate unanimously in 2008, this month aims to spread awareness about this disease and the importance of carrier…

Continue Reading In Honor of Tay-Sachs Disease Awareness Month Organizations are Teaming Together to Spread Awareness of Genetic Testing
After Facing Her Son’s Diagnosis, This Mom Started to Lead a PFIC Support Organization
rawpixel / Pixabay

After Facing Her Son’s Diagnosis, This Mom Started to Lead a PFIC Support Organization

According to a story from delmarvanow.com, a nine year old boy named Trey Kearns has progressive familial intrahepatic cholestasis (PFIC) a rare disease that affects the liver. The symptom that…

Continue Reading After Facing Her Son’s Diagnosis, This Mom Started to Lead a PFIC Support Organization
After Visiting Nearly 100 Doctors, This Man Still Doesn’t Have a Diagnosis for His Rare Disease
Free-Photos / Pixabay

After Visiting Nearly 100 Doctors, This Man Still Doesn’t Have a Diagnosis for His Rare Disease

According to a story from the Washington Post, Bob Schwartz is a walking, talking medical mystery. He lives with a strange and diverse array of difficult symptoms, and after being…

Continue Reading After Visiting Nearly 100 Doctors, This Man Still Doesn’t Have a Diagnosis for His Rare Disease
Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension
Bokskapet / Pixabay

Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension

According to a story from Benzinga, the medical device company V-Wave Ltd. has recently announced that a product in development by the company has earned Breakthrough Device designation from the…

Continue Reading Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension
Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
argzombies / Pixabay

Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease

According to a story from clinicaltrials.gov, the Children's Hospital of Philadelphia is sponsoring a study that has the potential to make mitochondrial disease research and drug development much easier. The…

Continue Reading Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug
rawpixel / Pixabay

ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug

According to a press release from CTD Holdings, the American Food and Drug Administration (FDA) recently approved an Expanded Access application from a physician to treat a pediatric Niemann-Pick disease…

Continue Reading ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug